Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Agency would like to purchase a new high-throughput platform for single-cell isolation, barcoding, and subsequent analysis via next-generation sequencing on an Illumina NextSeq 500 sequencer.
The main application will be RNA-Seq and the minimum number of cells processed per run should be >10,000. Quick laboratory workflows and compatibility of the system with a wide range of input samples such as fresh, frozen and fixed, would be beneficial.
Consumable costs will be an estimate.
Additional information: Consumable costs are an estimate. Actual consumable costs will depend on actual consumable usage.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Becton, Dickinson UK Ltd | 00852702 | £169,450 | LOBBYIST Policy Connect Limited (4 quarters) Healthcomms Consulting Ltd. (2 quarters) Newmarket Strategy Limited (1 quarter) Political Lobbying & Media Relations Limited (1 quarter) |
Government spending data: This supplier has received £623,660,369 in 1,859 payments (over £25k) from NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, UK Health Security Agency, BEIS, Manchester University NHS Foundation Trust and 9 more public bodies (2016-08-11 to 2026-02-13). View full payment history →